Drug Discovery of COPD


Chronic obstructive pulmonary disease is an increasing worldwide medical issue and cause of death. COPD predominantly influencing small airway routes and lung parenchyma that prompts dynamic aviation route deterrent. COPD is a standout amongst the most widely recognized infections on the globe, and there is a global increase in prevalence, however there are no drugs available at present that halt the relentless progression of this disease. In any case, a superior comprehension of the cell and molecular mechanisms that are associated with the underlying inflammatory and destructive processes has uncovered a few new focuses for which drugs are presently being developed, and the prospects for finding new medications are good.


  • LABA–LAMA
  • Bronchodilators
  • Inhaled corticosteroids

Related Conference of Drug Discovery of COPD

August 29-30, 2022

10th Annual Congress on Pulmonary and Critical Care

Amsterdam, Netherlands
August 29-30, 2022

12th International Conference on COPD and Lungs

Amsterdam, Netherlands
September 22-23, 2022

3rd International Conference on Lung Diseases

Amsterdam, Netherlands
November 07-08, 2022

13th International Conference on Pulmonary & Respiratory Medicine

Singapore City, Singapore
November 10-11, 2022

3rd International Conference on Hepatitis

Madrid, Spain
November 24-25, 2022

34th Global Summit Pulmonary Diseases & Treatment

Amsterdam, Netherlands

Drug Discovery of COPD Conference Speakers

Recommended Sessions

Related Journals

Are you interested in